Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA

T. Grellety; Florent Peyraud; Nicolas Sévenet; Olivier Trédan; Nadine Dohollou; Emmanuelle Barouk-Simonet; Michèle Kind; Michel Longy; Jean Yves Blay; Antoine Italiano

doi:10.1016/j.annonc.2020.03.283

Article2025

PARP inhibitors during conception and pregnancy in breast cancer

Zagouri Flora, Meletios A Dimopoulos, Αngeliki Andrikopoulou

Article2017

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquı́n Mateo, Wei Yuan, Helen Mossop, Núria Porta, Susana Miranda, Raquel Pérez-López, David Dolling, Dan R. Robinson, Shahneen Sandhu, Gemma Fowler, Berni Ebbs, Penny Flohr, George Seed, Daniel Nava Rodrigues, Gunther Boysen, Cláudia Bertan, Mark Atkin, Matthew Clarke, Mateus Crespo, Ines Figueiredo, Ruth Riisnaes, Semini Sumanasuriya, Pasquale Rescigno, Zafeiris Zafeiriou, Adam Sharp, Nina Tunariu, Diletta Bianchini, Alexa Gillman, Christopher J. Lord, Emma Hall, Arul M. Chinnaiyan, Suzanne Carreira, Johann S. de Bono

Article2011

P5-06-02: Response and Acquired Resistance of BRCA1-Deficient Triple-Negative Breast Cancer Xenografts to Alkylators or PARP Inhibitors.

Brugge P ter, der Burg E van, Petra Kristel, Ute Boon, Freixas C Moutinho, Manel Esteller, Frans B.L. Hogervorst, Heidi Gevensleben, Natalie Turner, Jelle Wesseling, J. Jonkers

Article2021

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors

Michalis Liontos, Evangelos Terpos, Christos Markellos, Flora Zagouri, Αlexandros Briasoulis, Ioanna Katsiana, Efthymia Skafida, Oraianthi Fiste, Elena Kunadis, Αngeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos

Preprint2023

Data from Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquı́n Mateo, Wei Yuan, Helen Mossop, Núria Porta, Susana Miranda, Raquel Pérez-López, David Dolling, Dan R. Robinson, Shahneen Sandhu, Gemma Fowler, Berni Ebbs, Penny Flohr, George Seed, Daniel Nava Rodrigues, Gunther Boysen, Cláudia Bertan, Mark Atkin, Matthew Clarke, Mateus Crespo, Ines Figueiredo, Ruth Riisnaes, Semini Sumanasuriya, Pasquale Rescigno,

Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA

Discussion(0)

Related publications

PARP inhibitors during conception and pregnancy in breast cancer

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

P5-06-02: Response and Acquired Resistance of BRCA1-Deficient Triple-Negative Breast Cancer Xenografts to Alkylators or PARP Inhibitors.

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors

Data from Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition